SUNESIS PHARMACEUTICALS INC's ticker is and the CUSIP is 867328901. A total of 3 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $72,000 | -13.3% | 131,600 | -13.9% | 0.00% | 0.0% |
| Q1 2016 | $83,000 | -57.2% | 152,900 | -29.1% | 0.00% | -50.0% |
| Q4 2015 | $194,000 | -2.5% | 215,600 | -12.0% | 0.00% | -33.3% |
| Q3 2015 | $199,000 | -56.7% | 245,100 | +60.4% | 0.00% | -50.0% |
| Q2 2015 | $460,000 | -28.9% | 152,800 | -42.1% | 0.01% | -40.0% |
| Q1 2015 | $647,000 | -7.6% | 263,900 | -3.9% | 0.01% | -9.1% |
| Q4 2014 | $700,000 | -86.3% | 274,700 | -61.6% | 0.01% | -86.1% |
| Q3 2014 | $5,102,000 | +1100.5% | 714,500 | +995.9% | 0.08% | +1028.6% |
| Q2 2014 | $425,000 | -57.8% | 65,200 | -57.2% | 0.01% | -58.8% |
| Q1 2014 | $1,008,000 | +600.0% | 152,500 | +401.6% | 0.02% | +750.0% |
| Q4 2013 | $144,000 | -27.6% | 30,400 | -24.2% | 0.00% | -50.0% |
| Q3 2013 | $199,000 | -4.8% | 40,100 | -0.2% | 0.00% | -20.0% |
| Q2 2013 | $209,000 | – | 40,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|